Dr Thomas Newsom-Davis

Dr Thomas Newsom-Davis



21 years of experience
11 years as a specialist


  • Medical Oncology
Show more

Languages spoken

  • English
Show more

Registered with

  • General Medical Council: 4529260
Show more

    Practices worked at

    LOC at Chelsea

    102 Sydney Street, Chelsea, London, United Kingdom, SW3 6NJ
    0 reviews

    Platinum Medical Centre

    15-17 Lodge Road, London, United Kingdom, NW8 7JA
    1355 reviews

    Sydney Street Outpatients and Diagnostics Centre

    Sydney Street Outpatients and Diagnostic Centre,102 Sydney Street Chelsea, London, United Kingdom, SW3 6NR
    35 reviews

    LOC - Leaders in Oncology Care

    95 Harley Street, London, United Kingdom, W1G 6AF
    225 reviews


    Dr Thomas Newsom-Davis a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, especially lung cancer and mesothelioma. In 2015, he was awarded the Macmillan Innovation Excellence Award.


    Dr Newsom-Davis completed his training at University College and Middlesex School of Medicine, London, in 1998, including First Class honours for his BSc. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals and completed a PhD in tumour immunology. He was appointed to Chelsea & Westminster Hospital in 2010.

    Current Roles

    Dr Newsom-Davis leads the lung cancer service for Chelsea & Westminster Hospital, and is Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organistion which supports and educates thoracic oncology profressionals across the United Kingdom. Dr Newsom-Davis is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT), and Chair of the HCA Healthcare UK Thoracic Oncology Board.


    Dr Newsom-Davis has an active clinical trial portfolio, and has presented his work at National and International meetings. He has been an invited lecturer for organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.

    It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

    Diseases, Medical Tests and Treatments

    • Immunotherapy, Targeted Therapy, Chemotherapy
    • Lung Cancer
    • Mesothelioma
    Read more

    Medical procedures

    • Immunotherapy
    • Biological Therapy
    • Targeted Therapy
    • Chemotherapy
    • Clinical Trials
    Read more

    Special interests

    • Lung Cancer
    • Mesothelioma
    • Primary Lung Tumours
    • Thymus Gland Cancer
    Read more



    MBBS (Hons) University College London Medical School 1998

    BSc Anatomy (1st Class Hon) University College London Medical School 1995

    PhD Imperial College London 2008


    FRCP Royal College of Physicians (London) 2014

    Read more
    This specialist has not collected any Doctify reviews


    Powered by Doctify
    Promoting trust & transparency in healthcare